Ondansetrone Aurobindo

Ondansetron, the active ingredient in Ondansetrone Aurobindo, is an antiemetic presented as a 4 mg tablet for oral use. It helps prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adult and pediatric patients. GNH USA supplies Ondansetrone Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is used to manage nausea and vomiting across several clinical pathways. - Chemotherapy‑induced nausea and vomiting: reduces the frequency and severity of CINV in cancer patients. - Radiation‑induced nausea and vomiting: helps prevent vomiting during or after radiation treatment. - Post‑operative nausea and vomiting: decreases the incidence of PONV after surgical procedures.

Side effects are generally mild but can vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Constipation: occasional bowel habit changes. - Diarrhoea: loose stools in a minority of patients. - Fatigue: feeling of tiredness or reduced energy. - Dizziness: transient light‑headed sensations.

Serious or Rare Side Effects: - Cardiac arrhythmia: QT‑interval prolongation that may lead to serious rhythm disturbances. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Serotonin syndrome: agitation, hyperreflexia, tremor when combined with other serotonergic drugs. - Hepatic dysfunction: elevated liver enzymes indicating liver stress. - Vision changes: blurred vision or transient visual disturbances.

Before initiating therapy, consider the following safety measures: - Cardiac assessment: evaluate baseline ECG in patients with known heart disease or electrolyte abnormalities. - Electrolyte monitoring: correct potassium or magnesium deficits before use. - Concomitant serotonergic drugs: avoid or monitor for serotonin syndrome. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Renal or hepatic impairment: dose adjustment may be required; monitor function. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture.

Ondansetron may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Apomorphine: together with the drug may cause severe hypotension. - Certain C‑     

Moderate